Determining eligibility for and preparation to kidney transplantation of a patient with Lynch syndrome - a case report and literature review.
Conclusions: The risk of recurrence or new development of cancer related to immunosuppressive treatment should be considered on a case-by-case basis. In patients with a history or high risk of cancer, immunosuppression protocols based on the m-TOR pathway inhibitors should be used, if possible. Oncological surveillance and early detection of new cancer lesions are also important.
PMID: 24614524 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Gozdowska J, Bieniasz M, Wszoła M, Kieszek R, Domagała P, Drozdowski J, Tomaszek A, Kwiatkowski A, Chmura A, Durlik M Tags: Ann Transplant Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Colectomy | Colorectal Cancer | Endoscopy | Genetics | Hereditary Nonpolyposis Colorectal Cancer | HNPCC | Kidney Transplant | Kidney Transplantation | Lynch Syndrome | PET Scan | Prednisone | Prograf | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology